vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and MARINE PRODUCTS CORP (MPX). Click either name above to swap in a different company.
MARINE PRODUCTS CORP is the larger business by last-quarter revenue ($64.6M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). MARINE PRODUCTS CORP runs the higher net margin — 3.7% vs -70.9%, a 74.6% gap on every dollar of revenue. On growth, MARINE PRODUCTS CORP posted the faster year-over-year revenue change (35.0% vs 8.1%). MARINE PRODUCTS CORP produced more free cash flow last quarter ($4.1M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -3.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.
CTKB vs MPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $64.6M |
| Net Profit | $-44.1M | $2.4M |
| Gross Margin | 52.9% | 19.6% |
| Operating Margin | -9.0% | 5.8% |
| Net Margin | -70.9% | 3.7% |
| Revenue YoY | 8.1% | 35.0% |
| Net Profit YoY | -557.1% | -44.6% |
| EPS (diluted) | — | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $64.6M | ||
| Q3 25 | $52.3M | $53.1M | ||
| Q2 25 | $45.6M | $67.7M | ||
| Q1 25 | $41.5M | $59.0M | ||
| Q4 24 | $57.5M | $47.8M | ||
| Q3 24 | $51.5M | $49.9M | ||
| Q2 24 | $46.6M | $69.5M | ||
| Q1 24 | $44.9M | $69.3M |
| Q4 25 | $-44.1M | $2.4M | ||
| Q3 25 | $-5.5M | $2.6M | ||
| Q2 25 | $-5.6M | $4.2M | ||
| Q1 25 | $-11.4M | $2.2M | ||
| Q4 24 | $9.6M | $4.3M | ||
| Q3 24 | $941.0K | $3.4M | ||
| Q2 24 | $-10.4M | $5.6M | ||
| Q1 24 | $-6.2M | $4.6M |
| Q4 25 | 52.9% | 19.6% | ||
| Q3 25 | 52.7% | 19.2% | ||
| Q2 25 | 52.3% | 19.1% | ||
| Q1 25 | 48.6% | 18.6% | ||
| Q4 24 | 58.5% | 19.2% | ||
| Q3 24 | 56.3% | 18.4% | ||
| Q2 24 | 54.6% | 18.9% | ||
| Q1 24 | 51.3% | 20.2% |
| Q4 25 | -9.0% | 5.8% | ||
| Q3 25 | -17.6% | 5.4% | ||
| Q2 25 | -23.3% | 7.1% | ||
| Q1 25 | -36.1% | 4.4% | ||
| Q4 24 | 5.2% | 7.7% | ||
| Q3 24 | -8.2% | 7.2% | ||
| Q2 24 | -18.3% | 8.3% | ||
| Q1 24 | -23.9% | 7.6% |
| Q4 25 | -70.9% | 3.7% | ||
| Q3 25 | -10.5% | 5.0% | ||
| Q2 25 | -12.2% | 6.1% | ||
| Q1 25 | -27.5% | 3.7% | ||
| Q4 24 | 16.8% | 8.9% | ||
| Q3 24 | 1.8% | 6.8% | ||
| Q2 24 | -22.4% | 8.0% | ||
| Q1 24 | -13.8% | 6.6% |
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $125.0M |
| Total Assets | $461.5M | $147.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $125.0M | ||
| Q3 25 | $378.6M | $126.3M | ||
| Q2 25 | $377.6M | $127.2M | ||
| Q1 25 | $379.6M | $126.4M | ||
| Q4 24 | $395.7M | $129.0M | ||
| Q3 24 | $385.5M | $128.8M | ||
| Q2 24 | $389.1M | $129.3M | ||
| Q1 24 | $392.6M | $151.4M |
| Q4 25 | $461.5M | $147.2M | ||
| Q3 25 | $494.9M | $179.5M | ||
| Q2 25 | $493.3M | $173.2M | ||
| Q1 25 | $482.6M | $182.9M | ||
| Q4 24 | $499.5M | $171.2M | ||
| Q3 24 | $491.2M | $176.3M | ||
| Q2 24 | $483.7M | $175.7M | ||
| Q1 24 | $492.1M | $204.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $4.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $4.1M |
| FCF MarginFCF / Revenue | -2.9% | 6.4% |
| Capex IntensityCapex / Revenue | 1.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 2.00× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $4.7M | ||
| Q3 25 | $-3.9M | $2.6M | ||
| Q2 25 | $108.0K | $-1.6M | ||
| Q1 25 | $-125.0K | $10.8M | ||
| Q4 24 | $2.0M | $4.6M | ||
| Q3 24 | $13.2M | $5.1M | ||
| Q2 24 | $6.2M | $3.8M | ||
| Q1 24 | $4.0M | $15.9M |
| Q4 25 | $-1.8M | $4.1M | ||
| Q3 25 | $-4.6M | $2.1M | ||
| Q2 25 | $-1.5M | $-2.0M | ||
| Q1 25 | $-974.0K | $10.7M | ||
| Q4 24 | $1.1M | $3.6M | ||
| Q3 24 | $12.2M | $3.2M | ||
| Q2 24 | $5.2M | $3.0M | ||
| Q1 24 | $3.4M | $15.0M |
| Q4 25 | -2.9% | 6.4% | ||
| Q3 25 | -8.7% | 4.0% | ||
| Q2 25 | -3.2% | -3.0% | ||
| Q1 25 | -2.3% | 18.1% | ||
| Q4 24 | 1.9% | 7.6% | ||
| Q3 24 | 23.7% | 6.5% | ||
| Q2 24 | 11.0% | 4.4% | ||
| Q1 24 | 7.6% | 21.7% |
| Q4 25 | 1.6% | 0.9% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 2.1% | ||
| Q3 24 | 2.0% | 3.8% | ||
| Q2 24 | 2.3% | 1.1% | ||
| Q1 24 | 1.3% | 1.3% |
| Q4 25 | — | 2.00× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | -0.39× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | 0.21× | 1.09× | ||
| Q3 24 | 14.05× | 1.51× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | 3.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MPX
| Boats And Accessories | $63.4M | 98% |
| Parts | $1.1M | 2% |
